These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 29227280)

  • 21. p53-insensitive PUMA down-regulation is essential in the early phase of liver regeneration after partial hepatectomy in mice.
    Chen S; Zheng J; Hao Q; Yang S; Wang J; Chen H; Chen L; Zhou Y; Yu C; Jiao B; Cai Z
    J Hepatol; 2010 Jun; 52(6):864-71. PubMed ID: 20413175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polarized cell migration induces cancer type-specific CD133/integrin/Src/Akt/GSK3β/β-catenin signaling required for maintenance of cancer stem cell properties.
    Su YJ; Lin WH; Chang YW; Wei KC; Liang CL; Chen SC; Lee JL
    Oncotarget; 2015 Nov; 6(35):38029-45. PubMed ID: 26515729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PRIMA-1 induces apoptosis by inhibiting JNK signaling but promoting the activation of Bax.
    Wang T; Lee K; Rehman A; Daoud SS
    Biochem Biophys Res Commun; 2007 Jan; 352(1):203-12. PubMed ID: 17113036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apoptosis induced by proteasome inhibition in cancer cells: predominant role of the p53/PUMA pathway.
    Concannon CG; Koehler BF; Reimertz C; Murphy BM; Bonner C; Thurow N; Ward MW; Villunger A; Strasser A; Kögel D; Prehn JH
    Oncogene; 2007 Mar; 26(12):1681-92. PubMed ID: 16983338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, Puma, and Noxa.
    Valente LJ; Gray DH; Michalak EM; Pinon-Hofbauer J; Egle A; Scott CL; Janic A; Strasser A
    Cell Rep; 2013 May; 3(5):1339-45. PubMed ID: 23665218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of ROS and subsequent DNA-damage response in PUMA-induced apoptosis of ovarian cancer cells.
    Yang J; Zhao X; Tang M; Li L; Lei Y; Cheng P; Guo W; Zheng Y; Wang W; Luo N; Peng Y; Tong A; Wei Y; Nie C; Yuan Z
    Oncotarget; 2017 Apr; 8(14):23492-23506. PubMed ID: 28423586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HOXD3 Plays a Critical Role in Breast Cancer Stemness and Drug Resistance.
    Zhang Y; Zhang Q; Cao Z; Huang Y; Cheng S; Pang D
    Cell Physiol Biochem; 2018; 46(4):1737-1747. PubMed ID: 29698974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bryostatin 5 induces apoptosis in acute monocytic leukemia cells by activating PUMA and caspases.
    Wang Y; Zhang J; Wang Q; Zhang T; Yang Y; Yi Y; Gao G; Dong H; Zhu H; Li Y; Lin H; Tang H; Chen X
    Eur J Pharmacol; 2013 Oct; 718(1-3):340-9. PubMed ID: 24036350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An EGFR/Src-dependent β4 integrin/FAK complex contributes to malignancy of breast cancer.
    Tai YL; Chu PY; Lai IR; Wang MY; Tseng HY; Guan JL; Liou JY; Shen TL
    Sci Rep; 2015 Nov; 5():16408. PubMed ID: 26549523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Wild-type p53 upregulates an early onset breast cancer-associated gene GAS7 to suppress metastasis via GAS7-CYFIP1-mediated signaling pathway.
    Chang JW; Kuo WH; Lin CM; Chen WL; Chan SH; Chiu MF; Chang IS; Jiang SS; Tsai FY; Chen CH; Huang PH; Chang KJ; Lin KT; Lin SC; Wang MY; Uen YH; Tu CW; Hou MF; Tsai SF; Shen CY; Tung SL; Wang LH
    Oncogene; 2018 Jul; 37(30):4137-4150. PubMed ID: 29706651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein stability of p53 targets determines their temporal expression dynamics in response to p53 pulsing.
    Hanson RL; Porter JR; Batchelor E
    J Cell Biol; 2019 Apr; 218(4):1282-1297. PubMed ID: 30745421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The ubiquitin ligase COP1 regulates cell cycle and apoptosis by affecting p53 function in human breast cancer cell lines.
    Ka WH; Cho SK; Chun BN; Byun SY; Ahn JC
    Breast Cancer; 2018 Sep; 25(5):529-538. PubMed ID: 29516369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TAT-RasGAP317-326 requires p53 and PUMA to sensitize tumor cells to genotoxins.
    Michod D; Widmann C
    Mol Cancer Res; 2007 May; 5(5):497-507. PubMed ID: 17510315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of p53 up-regulated modulator of apoptosis and phosphorylated Akt in melanoma cell growth, apoptosis, and patient survival.
    Karst AM; Dai DL; Cheng JQ; Li G
    Cancer Res; 2006 Sep; 66(18):9221-6. PubMed ID: 16982766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p53-Dependent PUMA to DRAM antagonistic interplay as a key molecular switch in cell-fate decision in normal/high glucose conditions.
    Garufi A; Pistritto G; Baldari S; Toietta G; Cirone M; D'Orazi G
    J Exp Clin Cancer Res; 2017 Sep; 36(1):126. PubMed ID: 28893313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PUMA-mediated apoptosis in fibroblast-like synoviocytes does not require p53.
    You X; Boyle DL; Hammaker D; Firestein GS
    Arthritis Res Ther; 2006; 8(6):R157. PubMed ID: 17014719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. UV radiation resistance-associated gene (UVRAG) promotes cell proliferation, migration, invasion by regulating cyclin-dependent kinases (CDK) and integrin-β/Src signaling in breast cancer cells.
    Sencan S; Tanriover M; Ulasli M; Karakas D; Ozpolat B
    Mol Cell Biochem; 2021 May; 476(5):2075-2084. PubMed ID: 33515382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Harnessing the p53-PUMA axis to overcome DNA damage resistance in renal cell carcinoma.
    Zhou X; Tolstov Y; Arslan A; Roth W; Grüllich C; Pahernik S; Hohenfellner M; Duensing S
    Neoplasia; 2014 Dec; 16(12):1028-35. PubMed ID: 25499216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcription factor Sox4 is required for PUMA-mediated apoptosis induced by histone deacetylase inhibitor, TSA.
    Jang SM; Kang EJ; Kim JW; Kim CH; An JH; Choi KH
    Biochem Biophys Res Commun; 2013 Aug; 438(2):445-51. PubMed ID: 23916609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic Response to Non-genotoxic Activation of p53 by Nutlin3a Is Driven by PUMA-Mediated Apoptosis in Lymphoma Cells.
    Valente LJ; Aubrey BJ; Herold MJ; Kelly GL; Happo L; Scott CL; Newbold A; Johnstone RW; Huang DC; Vassilev LT; Strasser A
    Cell Rep; 2016 Mar; 14(8):1858-66. PubMed ID: 26904937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.